The Association Between Rheumatoid Arthritis and Atrial Fibrillation: Epidemiology, Pathophysiology and Management
Yezhou Qian,Zhangli Fei,Feige Nian
DOI: https://doi.org/10.2147/IJGM.S406926
IF: 2.145
2023-05-18
International Journal of General Medicine
Abstract:Yezhou Qian, 1 Zhangli Fei, 2 Feige Nian 2 1 Department of Cardiology, The First Hospital of Jiaxing, The Affiliated Hospital of Jiaxing University, Jiaxing, People's Republic of China; 2 Department of Rheumatology, The First Hospital of Jiaxing, The Affiliated Hospital of Jiaxing University, Jiaxing, People's Republic of China Correspondence: Feige Nian, Department of Rheumatology, The First Hospital of Jiaxing, The Affiliated Hospital of Jiaxing University, No. 1882 Zhong Huan Road, Jiaxing, 314000, People's Republic of China, Tel +8619884323170, Email Atrial fibrillation (AF) is the most common cardiac arrhythmia with a significant increase in morbidity and mortality worldwide. Rheumatoid arthritis (RA), as a systemic inflammatory disease, affecting 0.5– 1.0% of the adult population, is associated with increased incidence of cardiac arrhythmias such as AF. Several epidemiologic studies find that the risk of AF is increased in RA when compared with the general population. Other studies are inconsistent. Considering that inflammation plays an important role in AF, RA may be involved in the occurrence and development of AF. This review summarizes the epidemiology, pathophysiology, and management of AF in patients with RA. Keywords: atrial fibrillation, rheumatoid arthritis, epidemiology, pathophysiology, management Rheumatoid arthritis (RA) is a systemic inflammatory joint disease, affects 0.5–1.0% of the adult population, and is associated with an increased mortality rate. 1 RA is autoimmune and is generally characterized by autoantibodies to immunoglobulin G (IgG). 2 The utilization of biologic disease-modifying anti-rheumatic drugs (bDMARDs) improves long-term prognosis of RA patients. 3 Besides being a cause of joint structural damage, 4 many diseases are associated with RA, including osteoporosis, 5 depression, 6 pulmonary disease, 7 hypertension, 8 cardiovascular disease (CVD) 9 and cardiac arrhythmias. 10 The association between CVD and RA is well established and the risk of CVD in RA patients is 1.5 times higher compared to the general population. 11,12 CVD is the most common cause of death in RA. 13 In addition to accelerating the development of atherosclerosis, RA is associated with increased incidence of cardiac arrhythmias, especially in women. 14 Inflammatory cytokines such as interleukin (IL)-1, IL-6 and tumor necrosis factor- alpha (TNF-α) may play an important role in the cardiac electrophysiology. 15,16 Atrial fibrillation (AF), as the most common cardiac arrhythmia, affects more than 33 million people worldwide and is associated with a significant increase in morbidity and mortality. 17 The increased risk of stroke, dementia, heart failure, and death are associated with AF. 18 The management of AF mainly includes rate control, rhythm control, and stroke prophylaxis. 19 AF is promoted by advancing age, male sex, heart disease, hypertension, diabetes, obesity, stroke and alcohol overuse. 17,20 However, some individuals develop AF with no apparent risk factors, which suggests some underlying risk factors to AF. In patients with AF, inflammatory infiltrates have been observed in atrial tissues 21 and increased systemic inflammation appears to relate to the persistence of AF. 22 In the general population, inflammatory cytokines such as IL-1, IL-2, IL-6, IL-10 and TNF-α are associated with the presence, persistence and outcome of AF. 23,24 Under the premise that a systemic inflammatory state may contribute to AF, patients with chronic inflammatory conditions such as RA might be at an increased risk of developing AF. Moreover, growing studies suggest that the incidence of AF may be significantly increased in RA than in the general population. 25 Nevertheless, other researches have yielded inconsistent results. 26,27 Since systemic inflammation plays an important role in the pathogenesis of AF and RA is a disease characterized by chronic systemic inflammation, RA may play an important role in the occurrence and development of AF. In this article, we will review the epidemiology, pathophysiology, and management of AF in patients with RA. In a Danish nationwide cohort study, Lindhardsen et al report an overall 40% higher incidence of AF in patients with RA compared to the general population. 28 Besides, in patients with RA younger than 50, the relative risk of AF is increased threefold. It is worth noting that the study did not adjust for all cardiovascular risk factors due to the lack of relevant information. Using data from a large US commercial insurance plan, Kim et al show that the incidence of hospit -Abstract Truncated-
medicine, general & internal